These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19957867)

  • 21. Tissue plasminogen activator for the treatment of parapneumonic effusions in pediatric patients.
    Israel EN; Blackmer AB
    Pharmacotherapy; 2014 May; 34(5):521-32. PubMed ID: 24390857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrapleural urokinase in the management of parapneumonic empyema: a randomised controlled trial.
    Tuncozgur B; Ustunsoy H; Sivrikoz MC; Dikensoy O; Topal M; Sanli M; Elbeyli L
    Int J Clin Pract; 2001 Dec; 55(10):658-60. PubMed ID: 11777287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrapleural instillation of fibrinolytic agents for treatment of pleural empyema.
    Cochran JB; Tecklenburg FW; Turner RB
    Pediatr Crit Care Med; 2003 Jan; 4(1):39-43. PubMed ID: 12656540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current value of intrapleural fibrinolysis in the treatment of exudative fibrinous pleural effusions in pleural empyema and hemothorax].
    Kemper P; Köhler D
    Pneumologie; 1999 Aug; 53(8):373-84. PubMed ID: 10483276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early administration of intrapleural streptokinase in the treatment of multiloculated pleural effusions and pleural empyemas.
    Laisaar T; Püttsepp E; Laisaar V
    Thorac Cardiovasc Surg; 1996 Oct; 44(5):252-6. PubMed ID: 8948554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacotherapy in complicated parapneumonic pleural effusions and thoracic empyema.
    Schiza SE; Antoniou KM; Economidou FN; Siafakas NM
    Pulm Pharmacol Ther; 2005; 18(6):381-9. PubMed ID: 15998594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrapleural Fibrinolysis with Urokinase Versus Alteplase in Complicated Parapneumonic Pleural Effusions and Empyemas: A Prospective Randomized Study.
    Alemán C; Porcel JM; Alegre J; Ruiz E; Bielsa S; Andreu J; Deu M; Suñé P; Martínez-Sogués M; López I; Pallisa E; Schoenenberger JA; Bruno Montoro J; de Sevilla TF
    Lung; 2015 Dec; 193(6):993-1000. PubMed ID: 26423784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials.
    Nie W; Liu Y; Ye J; Shi L; Shao F; Ying K; Zhang R
    Clin Respir J; 2014 Jul; 8(3):281-91. PubMed ID: 24428897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
    Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
    Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrinolytics in the treatment of parapneumonic effusions.
    Bouros D; Schiza S; Siafakas N
    Monaldi Arch Chest Dis; 1999 Jun; 54(3):258-63. PubMed ID: 10441983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of febrinolytic therapy for treatment of pleural infection].
    Jin JM; Sun YC
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 May; 36(5):327-9. PubMed ID: 24047804
    [No Abstract]   [Full Text] [Related]  

  • 32. Once-daily vs. twice-daily intrapleural urokinase treatment of complicated parapneumonic effusion in paediatric patients: A randomised, prospective study.
    Wang JN; Yao CT; Yeh CN; Liu CC; Wu MH; Chuang HY; Wu JM
    Int J Clin Pract; 2006 Oct; 60(10):1225-30. PubMed ID: 16981967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The treatment of parapneumonic effusions and pleural empyemas].
    Hamm H
    Pneumologie; 2005 Oct; 59(10):696-703. PubMed ID: 16222582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complicated parapneumonic effusion and empyema thoracis: microbiology and predictors of adverse outcomes.
    Tsang KY; Leung WS; Chan VL; Lin AW; Chu CM
    Hong Kong Med J; 2007 Jun; 13(3):178-86. PubMed ID: 17548905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intra-pleural fibrinolytic therapy vs. conservative management in the treatment of parapneumonic effusions and empyema.
    Cameron R
    Cochrane Database Syst Rev; 2000; (3):CD002312. PubMed ID: 10908554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrapleural fibrinolytic therapy for pleural infection.
    Bouros D; Tzouvelekis A; Antoniou KM; Heffner JE
    Pulm Pharmacol Ther; 2007; 20(6):616-26. PubMed ID: 17049447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrapleural streptokinase in complicated parapneumonic effusions and empyema.
    Barthwal MS; Deoskar RB; Rajan KE; Chatterjee RS
    Indian J Chest Dis Allied Sci; 2004; 46(4):257-61. PubMed ID: 15515826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pleural effusion and empyema as complications of pneumonia].
    Bauwens AM; de Graaff CS; Boersma WG
    Ned Tijdschr Geneeskd; 2002 Mar; 146(10):464-9. PubMed ID: 11913110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of practice in the management of parapneumonic effusion and empyema in children.
    Griffith D; Boal M; Rogers T
    J Pediatr Surg; 2018 Apr; 53(4):644-646. PubMed ID: 28781127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema.
    Cameron R; Davies HR
    Cochrane Database Syst Rev; 2008 Apr; (2):CD002312. PubMed ID: 18425881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.